Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

AXS-12 reduced the frequency of cataplexy attacks per week compared with placebo (P =.017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with ...

Access to timely treatment for spinal muscular atrophy (SMA) remains a challenge, with barriers including delays in diagnosis, frequent treatment needs, and insurance coverage gaps, which impact ...

Bispecific antibodies enhance immune response by targeting myeloma and immune cells, showing high efficacy in multiple myeloma treatment. Tecvvayli, Talvey, and Elrexfio demonstrate significant ...

Frequency and perceived quality of nurse-led health coaching were positively associated with self-efficacy (r, 0.62; P .001), shared-decision making (r, 0.65; P .001), and treatment adherence (r, 0.57 ...

For people with hemophilia, deficiencies in factor VIII (hemophilia A) or factor IX (hemophilia B) lead to insufficient thrombin generation, which can lead to excessive or spontaneous bleeding. 3,7 In ...

--Novo Nordisk announced today that the US Food and Drug Administration approved Alhemo ® injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and ...

Tepmetko treatment in MET exon 14-altered NSCLC patients resulted in high side effect rates, with 99% experiencing any-grade and 68.4% severe side effects. Treatment-related side effects led to dose ...